abbvie glp-1 receptor agonist “Weighing In” on Agonists for People With HIV Schematic illustration of monoagonists, dual

Given the relatively smaller reduction in body weight (9.4%) in the SELECT trial compared to previous RCTs: 14.9% in STEP1 (BMI 37.86.7 kg/m 2 ) [16] and 13.2% STEP6 (BMI 31.9 kg/m 2 ) [49], pleiotropic effects of semaglutide may contribute to the overall CV risk reduction [25,37]

USE IN SPECIFIC POPULATIONS Safety and effectiveness of JANUVIA in children under 18 years have not been established

If side effects occur at higher doses, the medication dose should be lowered to the previously tolerated dose (Table 1)

Food and Drug Administration (FDA): Has systems in place to monitor and track reports of negative events related to prescription medications, including GLP-1 receptor agonists like Ozempic, Wegovy, and other similar drugs

Dulaglutide not only achieved glycemic control but also significantly reduced IL-6 and TNF levels and slowed the progression of kidney disease (Tuttle et al

If additional glycemic control is needed, the dose can be increased by 2.5 mg every 4 weeks, and the maximum dose of this drug is 15 mg once a week